Literature DB >> 11260525

Intracellular distribution and late endosomal effects of the ocular albinism type 1 gene product: consequences of disease-causing mutations and implications for melanosome biogenesis.

B Shen1, B Rosenberg, S J Orlow.   

Abstract

To investigate the function of ocular albinism type 1 (OA1), the gene responsible for X-linked ocular albinism, we employed a construct containing murine Oa1 fused to green fluorescent protein (GFP) in a heterologous COS cell expression system. The cellular distribution of wild-type (WT) Oa1 protein and Oa1 proteins reflecting mutations causing X-linked ocular albinism were examined. Comparison with different organelle markers revealed that Oa1-GFP localized to the late endolysosomal compartments. Some Oa1 mutant proteins failed to exit the endoplasmic reticulum (ER) (Class I mutants), while other mutants partially (Class II mutants) or fully (Class III mutants) exited the ER and trafficked to endolysosomal compartments. We observed that expression of WT Oa1-GFP in COS cells caused an apparent enlargement of late endosomes and a redistribution of the mannose-6-phosphate receptor (M6PR). None of the mutants displayed the full range of effects on the redistribution of M6PR exhibited by WT Oa1. The effects of Oa1 on late endosome structure and content are thus likely to reflect an important biological property of Oa1. We propose that OA1 is involved in reorganizing the endolysosomal compartment as a necessary step in ocular melanosome biogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11260525     DOI: 10.1034/j.1600-0854.2001.020306.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  19 in total

1.  Pink-eyed dilution protein controls the processing of tyrosinase.

Authors:  Kun Chen; Prashiela Manga; Seth J Orlow
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

2.  An unconventional dileucine-based motif and a novel cytosolic motif are required for the lysosomal and melanosomal targeting of OA1.

Authors:  Rosanna Piccirillo; Ilaria Palmisano; Giulio Innamorati; Paola Bagnato; Domenico Altimare; Maria Vittoria Schiaffino
Journal:  J Cell Sci       Date:  2006-04-18       Impact factor: 5.285

3.  Abnormal crossing of the optic fibres shown by evoked magnetic fields in patients with ocular albinism with a novel mutation in the OA1 gene.

Authors:  L Lauronen; R Jalkanen; J Huttunen; E Carlsson; S Tuupanen; S Lindh; H Forsius; E-M Sankila; T Alitalo
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

4.  Identification of quinolines that inhibit melanogenesis by altering tyrosinase family trafficking.

Authors:  Li Ni-Komatsu; Chunxiang Tong; Guangming Chen; Nelya Brindzei; Seth J Orlow
Journal:  Mol Pharmacol       Date:  2008-09-18       Impact factor: 4.436

Review 5.  Location-dependent signaling of the group 1 metabotropic glutamate receptor mGlu5.

Authors:  Yuh-Jiin I Jong; Ismail Sergin; Carolyn A Purgert; Karen L O'Malley
Journal:  Mol Pharmacol       Date:  2014-10-17       Impact factor: 4.436

Review 6.  Signaling pathways in melanosome biogenesis and pathology.

Authors:  Maria Vittoria Schiaffino
Journal:  Int J Biochem Cell Biol       Date:  2010-04-08       Impact factor: 5.085

7.  Dual loss of ER export and endocytic signals with altered melanosome morphology in the silver mutation of Pmel17.

Authors:  Alexander C Theos; Joanne F Berson; Sarah C Theos; Kathryn E Herman; Dawn C Harper; Danièle Tenza; Elena V Sviderskaya; M Lynn Lamoreux; Dorothy C Bennett; Graça Raposo; Michael S Marks
Journal:  Mol Biol Cell       Date:  2006-06-07       Impact factor: 4.138

8.  Interaction between G Protein-Coupled Receptor 143 and Tyrosinase: Implications for Understanding Ocular Albinism Type 1.

Authors:  Elisabetta De Filippo; Anke C Schiedel; Prashiela Manga
Journal:  J Invest Dermatol       Date:  2016-10-06       Impact factor: 8.551

9.  The ocular albinism type 1 gene product, OA1, spans intracellular membranes 7 times.

Authors:  Michio Sone; Seth J Orlow
Journal:  Exp Eye Res       Date:  2007-08-29       Impact factor: 3.467

10.  Does levodopa improve vision in albinism? Results of a randomized, controlled clinical trial.

Authors:  C Gail Summers; John E Connett; Ann M Holleschau; Jennifer L Anderson; Inge De Becker; Brian S McKay; Murray H Brilliant
Journal:  Clin Exp Ophthalmol       Date:  2014-05-05       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.